News Brief - PrEP

by Aaron Shepard
in News
Hits: 1477

News Brief PrEP

A recent study performed by Kaiser Permanente of San Francisco has definitively shown how effective of a daily regimen of Truvada can be in the prevention against HIV infection.  After monitoring 657 of its clients who were on PrEP over a two year period, Kaiser announced that none of the subjects had contracted the virus.

Dr. Jonathan E. Volk, an epidemiologist for Kaiser Permanente of San Francisco, and his colleagues monitored a group of men who were prone to risky sexual behavior.  While the men used fewer condoms during this time period, none of them became HIV-positive.

“This is very reassuring data,”Dr. Jonathan E. Volk stated.  “It tells us that PrEP works even in a high-risk population.”

All but four of the participants in the study were gay men, and 84 percent of them reported sexual activity with multiple partners.  After six months of being on PrEP, 143 of the subjects were asked about their sexual behavior.  More than 40% of them stated they were using condoms less, and 74% of that group said that their number of sexual partners had not changed.  Don’t go throwing out your supply of condoms just yet, though.  Half of the 657 participants became infected with syphilis, gonorrhea or chlamydia within the first year! Co-author Julia Marcus stressed, “Without a control group, we don’t know if these STI rates were higher than what we would have seen without PrEP.  Ongoing screening and treatments for STIs, including hepatitis C, are an essential component of a PrEP treatment program.”

The fight against HIV will continue, but if this study shows us anything it is that PrEP is our greatest weapon!  

News Brief PrEP